Maybe the PMX and the 2-1 TIGRIS Should be better explained to the market.
The idea of the TIGRIS being restarted is a bit of a farce, 5 years after the phase 3 Rollercoaster. From failure to a 75% weighting in a the confirmatory phase 3B, is there a paper yet?
CTSO being seemingly used on thousands with an EUA and very little supportive data. Now we learn through Lancet, it is potentially dangerous?
spectrals full theranostic system in Canada fully approved since 2010 and to the best of my knowledge NO USAGE!! Nevermind CV19, what about Canadian Sepsis patients?
Go ahead close your CV19 deal in the US, but given it is FULLy approved in Canada, what is going on with Canadian use?
Remember, CTSO has been approved by Health Canada!! Based on what?
The EU producing more PMX and covid19 data in the coming days. What is going on Spectral? The cv19 trial in the US was our only > 2 filter NA experiment, how many patients did you run and how did the additional filter option impact the patient, EAA levels and of course mortality?
Good AGM questions
Best,
Gadge